AKT2 and small cell lung carcinoma: Other acquired resistance mechanisms, including small cell lung cancer or squamous cell transformation, mutation in PIK3CA, BRAF, HER2, KRAS, NRAS, MEK1, AKT2, LKB1 and JAK2, were not detected.